Answers are grounded in this paper and cite their sources.
Drawing on an ethnographic study of French precision oncology clinical trials, this paper introduces the notion of “experimenting organization” to investigate recent developments in the clinical research domain but also, concurrently, in routine treatments and care. Experimenting organizations simultaneously engage in experimental activities by producing new knowledge and practices, while also experimenting with new ways of organizing the production of knowledge. We discuss a number of elements that characterize this kind of organization, namely: a close intertwining of routine and experimental activities; the search for a balance between continuity and discontinuity and, relatedly, logistical flexibility and robustness; a micropolitics of cooperation as defined by soft organizational design and interrelations between organizations scattered across different socio-technical spaces, including international ones and, relatedly, a micropolitics of boundaries. All these processes are further defined by their reflexive nature—both vis-à-vis organizational design and the validation of experimental results—and by the central place attributed to coordination issues. This case is relevant beyond the field of oncology because many contemporary challenges in public policy can only be addressed by relying on, creating, and transforming the organizations—both public and private—that are responsible for producing public goods. Our article contributes to the analysis of both public policy and the organizations that implement these policy objectives.
No takes yet. Share an insight, caveat, or question.
Bergeron et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: